M&A Deal Summary

Eurofins Scientific Acquires DNA Diagnostics Center

On June 28, 2021, Eurofins Scientific acquired life science company DNA Diagnostics Center from GHO Capital Partners and Goldman Sachs Merchant Banking

Acquisition Highlights
  • This is Eurofins Scientific’s 65th transaction in the Life Science sector.
  • This is Eurofins Scientific’s 28th transaction in the United States.
  • This is Eurofins Scientific’s 2nd transaction in Ohio.

M&A Deal Summary
Date 2021-06-28
Target DNA Diagnostics Center
Sector Life Science
Buyer(s) Eurofins Scientific
Sellers(s) GHO Capital Partners
Goldman Sachs Merchant Banking
Deal Type Add-on Acquisition

Target

DNA Diagnostics Center

Fairfield, Ohio, United States
DNA Diagnostics Center is a provider of private DNA testing services for paternity and other family relationships, forensics, cell line authentication, and ancestry. DDC provides products approved by the FDA and EMA, and is accredited by the American Association of Blood Banks (AABB), The Ministry of Justice, The College of American Pathologists (CAP), and The Clinical Laboratory Improvement Amendment (CLIA). DNA Diagnostics Center was founded in 1995 and is based in Fairfield, Ohio.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Eurofins Scientific

Luxembourg, Luxembourg
Category Company
Founded 1987
Sector Life Science
Employees62,000
Revenue 6.5B EUR (2023)
DESCRIPTION

Eurofins Scientific is an international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins Scientific was incorporated in 1987 and is based in Luxembourg City.

DEAL STATS #
Overall 87 of 98
Sector (Life Science) 65 of 74
Type (Add-on Acquisition) 64 of 73
State (Ohio) 2 of 2
Country (United States) 28 of 31
Year (2021) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-18 Beacon Discovery

San Diego, California, United States

Beacon Discovery is a preeminent drug discovery and contract research organization (CRO) focused on G-Protein Coupled Receptor (GPCR) research. GPCRs provide unexploited opportunities to develop novel drugs addressing significant unmet medical needs. In addition, Beacon collaborates with biopharma partners to leverage internally enabled GPCR targets and small-molecule modulators as well as its wealth of GPCR discovery skills and tools. Beacon Discovery was founded in 2016 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-10 G Lab

Hokkaido , Japan

G Lab is a molecular biology-based testing provider for diagnostics, biomarker development, and drug discovery. G Lab has developed a reputation among clinical communities in Japan for the CAP-accredited quality services provided by its technical experts, in-house medical pathologists, and cytotechnologists. G Lab was established in 2000 and is based in Hokkaido, Japan.

Buy -

Seller(S) 2

SELLER

GHO Capital Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 6.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, England.

DEAL STATS #
Overall 3 of 4
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 1 of 1
State (Ohio) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-08 Velocity Clinical Research

Durham, North Carolina, United States

Velocity Clinical Research is an integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity Clinical Research was founded in 2017 and is based in Durham, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-26 Sanner

Bensheim, Germany

Sanner is a provider of packaging solutions and components for the Pharmaceutical, Diagnostic, Nutraceutical and MedTech industries. Sanner is based in Schillerstrasse, Germany.

Buy -
SELLER

Goldman Sachs Merchant Banking

New York, New York, United States
Category Private Equity Firm
Founded 1986
PE ASSETS 155.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Goldman Sachs Merchant Banking Division is the investment arm of Goldman Sachs. The primary corporate investment group within the Merchant Banking Division is Goldman Sachs' direct investment arm. GS's direct investment arm consists of GS Capital Partners, GS Mezzanine Partners, and GS Growth Partners. GS Capital Partners is the direct corporate equity investment group which seeks LBO, recapitalization, and growth investments to help fund acquisitions, expansions, recapitalizations, restructurings, buyouts, and take privates. GS Capital Partners looks to invest between $50 and $800 million in opportunities in North/South America, Europe, Asia. GS Mezzanine Partners is the junior capital arm of Goldman Sachs. GS Mezzanine looks to invest between $200 million and and $800 million in transactions valued up to $10 billion. Investment proceeds are used to fund leveraged buyouts, expansion financings, recapitalizations, acquisitions, and restructurings. GS Growth looks to invest in growth equity transactions. The unit seeks to commit $20 to $200 million per investment. Other units within GS's merchant banking division include Real Estate, Infrastructure, and Urban Investments. Goldman Sachs Merchant Banking Division is based in New York City.

DEAL STATS #
Overall 98 of 110
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 32 of 37
State (Ohio) 5 of 5
Country (United States) 71 of 78
Year (2021) 9 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-24 Navico

Tulsa, Oklahoma, United States

Navico is a provider in marine electronics for the recreational segment and is an innovative force within the commercial marine market. Navico offers multi-function displays, fish finders, autopilots, sonar, radar, and cartography. Navico strong brands serve most major powerboat and sailing markets for both recreational and commercial applications. Navico was founded in 2006 and is based in Tulsa, Oklahoma.

Sell $1.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-02 Parexel

Durham, North Carolina, United States

Parexel is a global provider of clinical research and consulting services to the pharma and biotech industry. Parexel’s services enable the development of innovative new medicines that improve the health of patients across the world. Parexel was founded in 1983 and is based in Durham, North Carolina.

Buy $8.5B
Mergr

Product

Company

Legal